Renoprotective and Immunomodulatory Effects of GDF15 following AKI Invoked by Ischemia-Reperfusion Injury
- 7 February 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 31 (4), 701-715
- https://doi.org/10.1681/asn.2019090876
Abstract
Background Gdf15 encodes a TGF-β superfamily member that is rapidly activated in response to stress in multiple organ systems, including the kidney. However, there has been a lack of information about Gdf15 activity and effects in normal kidney and in AKI. Methods We used genome editing to generate a Gdf15nuGFP-CE mouse line, removing Gdf15 at the targeted allele, and enabling direct visualization and genetic modification of Gdf15-expressing cells. We extensively mapped Gdf15 expression in the normal kidney and following bilateral ischemia-reperfusion injury, and quantified and compared renal responses to ischemia-reperfusion injury in the presence and absence of GDF15. In addition, we analyzed single nucleotide polymorphism association data for GDF15 for associations with patient kidney transplant outcomes. Results Gdf15 is normally expressed within aquaporin 1–positive cells of the S3 segment of the proximal tubule, aquaporin 1–negative cells of the thin descending limb of the loop of Henle, and principal cells of the collecting system. Gdf15 is rapidly upregulated within a few hours of bilateral ischemia-reperfusion injury at these sites and new sites of proximal tubule injury. Deficiency of Gdf15 exacerbated acute tubular injury and enhanced inflammatory responses. Analysis of clinical transplantation data linked low circulating levels of GDF15 to an increased incidence of biopsy-proven acute rejection. Conclusions Gdf15 contributes to an early acting, renoprotective injury response, modifying immune cell actions. The data support further investigation in clinical model systems of the potential benefit from GDF15 administration in situations in which some level of tubular injury is inevitable, such as following a kidney transplant.Keywords
Funding Information
- California Institute of Regenerative Medicine (53-5178-7980)
- Swiss National Science Foundation (167773)
- National Institutes of Health (U01HG004085, U01HG004080, U42RR024244)
This publication has 74 references indexed in Scilit:
- Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many GenesCell, 2013
- Imputing Amino Acid Polymorphisms in Human Leukocyte AntigensPLOS ONE, 2013
- Temperature Response of Soil Respiration in a Chinese Pine Plantation: Hysteresis and Seasonal vs. Diel Q10PLOS ONE, 2013
- Cellular pathophysiology of ischemic acute kidney injuryJCI Insight, 2011
- Osmoprotective proteome adjustments in mouse kidney papillaBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2011
- Regulation of GDF-15, a distant TGF-β superfamily member, in a mouse model of cerebral ischemiaCell and tissue research, 2010
- Dual RMCE for efficient re-engineering of mouse mutant allelesNature Methods, 2010
- A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association StudiesPLoS Genetics, 2009
- HLAMatchmaker: A Molecularly Based Algorithm for Histocompatibility Determination. V. Eplet Matching for HLA-DR, HLA-DQ, and HLA-DPHuman Immunology, 2007
- Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursorsProceedings of the National Academy of Sciences of the United States of America, 2006